Subscribe To
Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR : Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced several developments in its infectious disease and oncology portfolios. These include: […] The post Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference appeared firs...
Read More
Posted: Jan 8 2023, 20:00
Author Name: forextv
Views: 103188